Brief: Societal Cdmo Selected By Xequel Bio To Provide Cdmo Services To Support Ongoing Clinical Development Of Inexin
08/05/2023 15:22
May 8 (Reuters) - Societal CDMO Inc SCTL.O :
* SOCIETAL CDMO SELECTED BY XEQUEL BIO TO PROVIDE CDMO
SERVICES TO
SUPPORT ONGOING CLINICAL DEVELOPMENT OF INEXIN™
Source text for Eikon: ID:nGNX3dh22k
Further company coverage: SCTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Societal CDMO
See all newsBrief: Corerx Inc Completes Acquisition Of Societal CDMO Inc
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Brief: Societal CDMO Inc Received Notice From Nasdaq Stating Co Regained Compliance With Nasdaq Listing Rule 5550(A)(2) On March 14
Brief: Societal Cdmo Enters Into Definitive Agreement To Be Acquired By Corerx, Inc.
Societal CDMO Inc expected to post a loss of 1 cent a share - Earnings Preview